Loading...

Cryo-Cell International, Inc.

CCEL•NASDAQ
Healthcare
Medical - Care Facilities
$3.70
$0.10(2.78%)
U.S. Market is Open • 12:07

Cryo-Cell International, Inc. (CCEL) Stock Overview

Explore Cryo-Cell International, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap29.6M
P/E Ratio-11.62
EPS (TTM)$-0.30
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$2.22
3 Months$1.60
1 Year Target$1.84

CCEL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cryo-Cell International, Inc. (CCEL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.62 and a market capitalization of 29.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.94%
5-Day Change
1.10%
1-Month Change
25.68%
3-Month Change
8.26%
6-Month Change
-19.16%
Year-to-Date (YTD) Change
6.69%
1-Year Change
-34.11%
3-Year Change
3.38%
5-Year Change
-62.36%
All-Time (Max) Change
-26.60%

Contact Information

https://www.cryo-cell.com
813 749 2100
700 Brooker Creek Boulevard, Oldsmar, FL, 34677

Company Facts

82 Employees
IPO DateApr 4, 1994
CountryUS
Actively Trading

Frequently Asked Questions